Benefit of adjuvant chemotherapy in resected stage I-IV CRC patients based on ctDNA dynamics across two timepoints: Results from GALAXY study.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Mitsuru Yokota, Hideaki Bando, Yoshiaki Nakamura, Daisuke Kotani, Saori Mishima, Koji Ando, Stephanie A. Sanchez, Kim Magee, Charuta C. Palsuledesai, Robert William Lentz, Adham A. Jurdi, Alexey Aleshin, Hiroya Taniguchi, Jun Watanabe, Takeshi Kato, Yusuke Suwa, Keiji Hirata, Naoya Akazawa, Takayuki Yoshino, Eiji Oki
Institutions: Kurashiki Central Hospital, National Cancer Center Hospital East, Kyushu University, Aichi Cancer Center, Kansai Medical University, Osaka National Hospital, Yokohama City University Medical Center, University of Occupational and Environmental Health Japan, Sendai Medical Center, Sendai City Medical Center, Sendai Open Hospital, Kyushu University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162489304
Cites:
Cited by:
Related to: